Cellectis (CLLS) Net Margin (2015 - 2026)

Cellectis' (CLLS) quarterly Net Margin came in at 0.0% in Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and down 52.39% quarter-over-quarter from 0.0% in Q4 2025.

Cellectis (CLLS) Net Margin (2015 - 2026) Analysis & Trends

Cellectis' Net Margin history runs 12 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • On a quarterly basis, Net Margin changed 0.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 32.88%, a 5614.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 8857.0% from the prior year.
  • Net Margin declined to 0.0% in Q1 2026 per CLLS's latest filing, from 0.0% in the prior quarter.
  • Across five years, Net Margin topped out at 124.62% in Q1 2024 and bottomed at 21635.97% in Q1 2023.
  • The 5-year median for Net Margin is 167.34% (2022), against an average of 4381.49%.
  • Across the five-year window, Net Margin tumbled 1971939 bps in 2023 and soared 2176060 bps in 2024, its largest moves.
  • Year by year, Net Margin stood at 167.34% in 2022, then plunged by 8725 bps to 14768.55% in 2023, then surged by 100 bps to 46.57% in 2024, then sank by 100 bps to 0.0% in 2025, then tumbled by 52 bps to 0.0% in 2026.
  • Per Business Quant, the three latest CLLS Net Margin figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 1.67% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cellectis 281.48 Mn 95.81 Mn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 1.67%
Jun 30, 2025 -141.92%
Mar 31, 2025 0.00%
Dec 31, 2024 46.57%
Sep 30, 2024 -142.32%
Jun 30, 2024 -313.48%
Mar 31, 2024 124.62%
Dec 31, 2023 -14,768.55%
Sep 30, 2023 -11,278.71%
Jun 30, 2023 -6,576.97%
Mar 31, 2023 -21,635.97%
Dec 31, 2022 -167.34%
Sep 30, 2022 -16,266.86%
Jun 30, 2022 -1,449.58%
Mar 31, 2022 -1,916.58%
Dec 31, 2021 -243.59%
Sep 30, 2021 -450.11%
Jun 30, 2021 -357.19%